AI Agents
Desktop
API & Integration
Pricing
Blog
AI Agents
IP Search Agents
Novelty Search
FTO Search
Design FTO Search
IP Drafting Agents
SEP Agents
Engineering Agents
Find Solutions with TRIZ
Life Sciences Agents
SAR Data Extraction
Lead Compound
Materials Agents
Desktop
API & Integration
Pricing
Blog
IP Search Agents
Novelty Search
FTO Search
Design FTO Search
IP Drafting Agents
SEP Agents
Engineering Agents
Find Solutions with TRIZ
Life Sciences Agents
SAR Data Extraction
Lead Compound
Materials Agents
Eureka Desktop Now Available
Download now
Patents
Literature
Patsnap Eureka AI that helps you search prior art, draft patents, and assess FTO risks, powered by patent and scientific literature data.
1
results about How to "Achieve prevention" patented technology
Filter
Efficacy Topic
Property
Owner
Technical Advancement
Application Domain
Technology Topic
Technology Field Word
Patent Country/Region
Patent Type
Patent Status
Application Year
Inventor
A composition for preventing cataract, maculopathy and diabetic retinopathy, and a method of preparation and use thereof
Active
CN121243255B
Inhibit oxidative denaturation
suppress generation
Senses disorder
Hydroxy compound active ingredients
Macula lutea degeneration
Astaxanthin
The present application provides a kind of composition and preparation method and application for preventing cataract, macular
lesion
and
diabetic retinopathy
, belong to biological
medicine
technical field.The composition of the present application includes: nano
active ingredient
,
plant
extract, glycyrrhizic acid dipotassium,
nicotinamide
,
taurine
, ikdoin,
caffeine
and
lutein
;
Plant
extract is composed of wild
chrysanthemum flower
extract and
gentian extract
;Nano
active ingredient
is composed of nano-encapsulated
astaxanthin
and nanometer
retinol
.The composition of the present application effectively inhibits key
pathological
links such as lens
protein
oxidative denaturation,
retinal
pigment
epithelial
cell
function decline and
pathological
angiogenesis
by multi-dimensional
synergistic mechanism
of
antioxidant
-anti-inflammatory-vascular protection-
metabolic regulation
, thereby realizing the prevention and
adjuvant
therapy effect on three major blinding eye diseases of cataract, age-related
macular degeneration
and
diabetic retinopathy
.
View all
Owner:
ANHETANG (GUANGZHOU) PHARMACEUTICAL BIOTECHNOLOGY CO LTD
+1
Login to View More